Stocks › ATHA
ATHA
ATHA·USD
—
No end-of-day price on record
ATHA
ATHA
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ATHAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ATHA by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Christopher L. JacobsHouse · R · NY |
ATHAATHA · Stock |
Purchase $1,001 - $15,000 |
Jan 20, 2023 | Dec 12, 2022 | Filing ↗ |
| Christopher L. JacobsHouse · R · NY |
ATHAATHA · Stock |
Sale $1,001 - $15,000 |
Dec 12, 2022 | Nov 8, 2022 | Filing ↗ |
| Christopher L. JacobsHouse · R · NY |
ATHAATHA · Stock |
Purchase $1,001 - $15,000 |
Sep 9, 2022 | Jul 18, 2022 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in ATHA among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ATHA insiders, by quarter · Form 4
Recent Insider Transactions
165 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Renninger RobertChief Financial Officer | Sale | −297 | $6.88 | $2K | Jan 2, 2026 | Form 4 ↗ |
| Worthington MarkGeneral Counsel and CCO | Sale | −876 | $6.88 | $6K | Jan 2, 2026 | Form 4 ↗ |
| CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Sale | −876 | $6.88 | $6K | Jan 2, 2026 | Form 4 ↗ |
| San Martin JavierCHIEF MEDICAL OFFICER | Sale | −1,644 | $6.88 | $11K | Jan 2, 2026 | Form 4 ↗ |
| Litton Mark JamesPresident and CEO · Director | Sale | −2,586 | $6.88 | $18K | Jan 2, 2026 | Form 4 ↗ |
| Renninger RobertChief Financial Officer | Option exercise | +1,236 | $0.00 | $0 | Dec 31, 2025 | Form 4 ↗ |
| Worthington MarkGeneral Counsel and CCO | Option exercise | +3,667 | $0.00 | $0 | Dec 31, 2025 | Form 4 ↗ |
| CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Option exercise | +3,667 | $0.00 | $0 | Dec 31, 2025 | Form 4 ↗ |
| San Martin JavierCHIEF MEDICAL OFFICER | Option exercise | +4,667 | $0.00 | $0 | Dec 31, 2025 | Form 4 ↗ |
| Litton Mark JamesPresident and CEO · Director | Option exercise | +10.8K | $0.00 | $0 | Dec 31, 2025 | Form 4 ↗ |
| PERCEPTIVE ADVISORS LLCDirector · 10% owner | Grant / award | +329.8K | $6.35 | $2.1M | Dec 23, 2025 | Form 4 ↗ |
| PERCEPTIVE ADVISORS LLCDirector · 10% owner | Grant / award | +989.3K | $6.35 | $6.3M | Dec 23, 2025 | Form 4 ↗ |
| Renninger RobertChief Financial Officer | Grant / award | +1,000 | $2.31 | $2K | Nov 18, 2025 | Form 4 ↗ |
| CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Grant / award | +1,000 | $2.31 | $2K | Nov 18, 2025 | Form 4 ↗ |
| CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Sale | −8,526 | $0.29 | $2K | Jul 1, 2025 | Form 4 ↗ |
| Litton Mark JamesPresident and CEO · Director | Sale | −25.1K | $0.29 | $7K | Jul 1, 2025 | Form 4 ↗ |
| San Martin JavierCHIEF MEDICAL OFFICER | Sale | −10.8K | $0.29 | $3K | Jul 1, 2025 | Form 4 ↗ |
| Worthington MarkGeneral Counsel and CCO | Sale | −8,526 | $0.29 | $2K | Jul 1, 2025 | Form 4 ↗ |
| Renninger RobertSVP, Finance and Accounting | Sale | −2,897 | $0.29 | $840 | Jul 1, 2025 | Form 4 ↗ |
| CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Option exercise | +36.7K | $0.00 | $0 | Jun 30, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ATHA · SEC Form N-PORT
Funds report their holdings by CUSIP, and ATHA could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming ATHA as client
No lobbying filings found naming ATHA as the client.
Government Contracts
Federal awards to ATHA · USAspending
No federal contract awards found for ATHA.
U.S. Patents
Recent USPTO applications naming ATHA
No USPTO patent applications found for ATHA.
Annual Financials
From ATHA's 10-K filings · XBRL
No annual XBRL figures on record for ATHA. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No price history on record for ATHA.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About ATHA
From SEC EDGAR company records
No company profile on record.